Astonea Labs Limited (BOM:544409)
324.00
0.00 (0.00%)
At close: Oct 12, 2026
Astonea Labs Revenue
In the fiscal year ending March 31, 2026, Astonea Labs had annual revenue of 1.48B INR with 51.34% growth. Astonea Labs had revenue of 812.93M in the half year ending March 31, 2026. That makes Astonea Labs the 35,217th largest company in the world by revenue and 2,814th in India.
Revenue
1.48B
Revenue Growth
+51.34%
P/S Ratio
2.31
Revenue / Employee
n/a
Employees
n/a
Market Cap
3.41B
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2026 | 1.48B | 500.66M | 51.34% |
| Mar 31, 2025 | 975.18M | 173.28M | 21.61% |
| Mar 31, 2024 | 801.91M | 131.40M | 19.60% |
| Mar 31, 2023 | 670.51M | 369.94M | 123.08% |
| Mar 31, 2022 | 300.57M | 7.30M | 2.49% |
| Mar 31, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Bilcare | 7.73B |
| Albert David | 3.64B |
| Medicamen Biotech | 2.06B |
| Ambalal Sarabhai Enterprises | 2.06B |
| Everest Organics | 1.92B |
| Gennex Laboratories | 1.78B |
| Jenburkt Pharmaceuticals | 1.69B |
| Trident Lifeline | 1.39B |